The cost-effectiveness of rotavirus vaccination in Malawi

Journal of Infectious Diseases

Volumn 202, Issue SUPPL. 1, 2010, Pages

  Berry, Stephen A ^a   Johns, Benjamin ^b   Shih, Chuck ^c   Berry, Andrea A ^d   Walker, Damian G ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Departments of International Health   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; CHILD; COST EFFECTIVENESS ANALYSIS; DISABILITY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MALAWI; MORTALITY; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; ROTAVIRUS INFECTION;

CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DECISION TREES; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; INFANT; INFANT, NEWBORN; MALAWI; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES;

EID: 77955674823     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/653578     Document Type: Article

References (35)

1. Parashar UD, Gibson CJ, Bresse JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006; 12(2):304-306.
2. Bernstein DI. Rotavirus overview. Pediatr Infect Dis J 2009; 28(3 Suppl):S50-S53.
3. Meeting of the Immunization Strategic Advisory Group of Experts, April 2009: conclusions and recommendations. Wkly Epidemiol Rec 2009; 84(23):220-236.
4. Introduction of rotavirus vaccine with support fromthe GAVI Alliance: information to assist the national decision-making and application process. http://www.gavialliance.org/resources/RVP-GAVI-InfoPack-17Jan08.pdf. Accessed 13 March 2009.
5. Cunliffe NA, Gondwe JS, Kirkwood CD, et al. Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children. Lancet 2001; 358(9281):550-555.
6. Velazquez FR, Matson DO, Calva JJ, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996; 335(14):1022-1028.
7. CIA World Factbook: Malawi. https://www.cia.gov/library/ publications/the-world-factbook/print/mi.html. Accessed 13 March 2009.
8. The Partnership for Maternal, Newborn, and Child Health-MNCH in Malawi. http://www.who.int/pmnch/countries/malawi/en/index.html. Accessed 13 March 2009.
9. Vaahtera M, Kulmala T, Maleta K, Cullinan T, Salin ML, Ashorn P. Epidemiology and predictors of infant morbidity in rural Malawi. Paediatr Perinat Epidemiol 2000; 14(4):363-371.
10. Cunliffe NA, Ngwira BM, Dove W, et al. Serotype g12 rotaviruses, Lilongwe, Malawi. Emerg Infect Dis 2009; 15(1):87-90.
11. World Health Organization. Immunization surveillance, assessment, and monitoring. http://www.who.int/immunization-monitoring/burden/ rotavirus-estimates/en/index.html. Accessed 27 May 2009.
12. Linhares AC, Velazquez FR, Perez-Schael I, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008; 371(9619):1181-1189.
13. World Health Organization. Immunization surveillance, assessment and monitoring. http://www.who.int/immunization-monitoring/diseases/ en. Accessed 13 March 2009.
14. Claeson M, Merson MH. Global progress in the control of diarrheal diseases. Pediatr Infect Dis J 1990; 9(5):345-355.
15. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003; 9(5):565-572.
16. Marsella M, Raimondi L, Bergamini M, et al. Epidemiology of rotavirus- associated hospital admissions in the province of Ferrara, Italy. Eur J Pediatr 2009; 168:1423-1427.
17. Gabutti G, Lazzara C, Marsella M, Bergamini M, Malaventura C, Borgna-Pignatti C. Burden of hospitalizations due to rotavirus infection in Emilia Romagna, Italy. Acta Biomed 2007; 78(3):176-181.
18. Charles MD, Holman RC, Curns AT, Parashar UD, Glass RI, Bresee JS. Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002. Pediatr Infect Dis J 2006; 25(6):489-493.
19. de Wit MA, Koopmans MP, van der Blij JF, van Duynhoven YT. Hospital admissions for rotavirus infection in the Netherlands. Clin Infect Dis 2000; 31(3):698-704.
20. Lopez-de-Andres A, Jimenez-Garcia R, Carrasco-Garrido P, Alvaro- Meca A, Galarza PG, de Miguel AG. Hospitalizations associated with rotavirus gastroenteritis in Spain, 2001-2005. BMC Public Health 2008; 8:109.
21. World Health Organization. Life Tables for WHO Member States. http: //www.who.int/whosis/database/life-tables/life-tables.cfm. Accessed 21 April 2009.
22. Murray C, Lopez A, eds. The global burden of disease. Boston: Harvard University Press, 1996.
23. The World Health Report 2002. Reducing risks, promoting healthy life. Geneva: World Health Organization, 2002.
24. Gravelle H, Smith D. Discounting for health effects in cost-benefit and cost-effectiveness analysis. Health Econ 2001; 10(7):587-599.
25. Tasset A, Nguyen VH, Wood S, Amazian K. Discounting: technical issues in economic evaluations of vaccination. Vaccine 1999; 17(Suppl 3):S75-S80.
26. Bilcke J, Beutels P. Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources. Pharmacoeconomics 2009; 27(4):281-97.
27. International Monetary Fund. World Economic Outlook Database. http://www.imf.org/external/pubs/ft/weo/2009/01/weodata/index aspx. Accessed 31 May 2009.
28. Dayan GH, Cairns L, Sangrujee N, Mtonga A, Nguyen V, Strebel P. Cost-effectiveness of three different vaccination strategies against measles in Zambian children. Vaccine 2004; 22:475-484.
29. Wolfson LJ, Gasse F, Lee-Martin SP, et al. Estimating the costs of achieving the WHO-UNICEF global immunization vision and strategy, 2006-2015. Bull World Health Organ 2008; 86(1):27-39.
30. World Health Organization. Choosing Interventions that are Cost Effective (WHO-CHOICE): Malawi. http://www.who.int/choice/country/ mwi/cost/en/index. html. Accessed 13 March 2009.
31. Muennig P. Designing and conducting cost-effectiveness analyses in medicine and health care. 1st ed. San Francisco: Jossey-Bass, 2002.
32. Macroeconomics and health: investing in health for economic development. http://whqlibdoc.who.int/publications/2001/924154550x.pdf. Accessed 24 June 2009.
33. Kim SY, Goldie SJ, Salomon JA. Cost-effectiveness of Rotavirus vaccination in Vietnam. BMC Public Health 2009; 9:29.
34. Comprehensive multi-year plan 2006-2010: Malawi. http://www gavialliance.org/performanc/country-results. Accessed 7 May 2009.
35. Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007; 370(9601):1757-1763.